Imidazenil

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameImidazenil
Drug Alias NameRO-231412FID-02023FGIN-2023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety DisordersCocaine-Related DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche LtdFidia Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdFidia Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersCocaine-Related DisordersEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A